B. Bibby

428 total citations
19 papers, 208 citations indexed

About

B. Bibby is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, B. Bibby has authored 19 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in B. Bibby's work include Cancer, Hypoxia, and Metabolism (8 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (5 papers). B. Bibby is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (5 papers). B. Bibby collaborates with scholars based in United Kingdom, Ireland and Canada. B. Bibby's co-authors include Stephen G. Maher, John V. Reynolds, Catharine West, Ananya Choudhury, Niamh Lynam‐Lennon, Robert G. Bristow, Niluja Thiruthaneeswaran, Jacintha O’Sullivan, Peter Hoskin and Brendan Ffrench and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

B. Bibby

17 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Bibby United Kingdom 9 113 107 60 47 41 19 208
Ghazal Haddad Canada 7 82 0.7× 141 1.3× 53 0.9× 68 1.4× 21 0.5× 8 223
Ольга Викторовна Николаева Russia 4 53 0.5× 128 1.2× 27 0.5× 68 1.4× 28 0.7× 10 314
Qiaomei Guo China 10 147 1.3× 174 1.6× 122 2.0× 81 1.7× 17 0.4× 14 306
Vandana Sandhu Norway 9 123 1.1× 129 1.2× 47 0.8× 107 2.3× 28 0.7× 11 251
Lori Kollath United States 5 60 0.5× 126 1.2× 140 2.3× 76 1.6× 23 0.6× 7 234
Anna Bellmunt Spain 3 72 0.6× 106 1.0× 43 0.7× 135 2.9× 23 0.6× 4 229
Lauren Carcas United States 4 54 0.5× 92 0.9× 54 0.9× 69 1.5× 42 1.0× 5 186
Rhafaela Lima Causin Brazil 9 150 1.3× 151 1.4× 24 0.4× 68 1.4× 15 0.4× 13 249
Ray Manneh Kopp Spain 9 44 0.4× 38 0.4× 83 1.4× 69 1.5× 22 0.5× 35 172
Qian Guo China 8 42 0.4× 80 0.7× 37 0.6× 83 1.8× 17 0.4× 33 180

Countries citing papers authored by B. Bibby

Since Specialization
Citations

This map shows the geographic impact of B. Bibby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Bibby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Bibby more than expected).

Fields of papers citing papers by B. Bibby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Bibby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Bibby. The network helps show where B. Bibby may publish in the future.

Co-authorship network of co-authors of B. Bibby

This figure shows the co-authorship network connecting the top 25 collaborators of B. Bibby. A scholar is included among the top collaborators of B. Bibby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Bibby. B. Bibby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Reardon, Mark, B. Bibby, Niluja Thiruthaneeswaran, et al.. (2024). Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 121(3). 752–760.
2.
Bibby, B., Lingjian Yang, Brian R. Lane, et al.. (2023). Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma. British Journal of Cancer. 128(12). 2307–2317. 4 indexed citations
3.
Davern, Maria, Martin P. Barr, Noel E. Donlon, et al.. (2022). Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses. Clinical and Experimental Medicine. 23(2). 411–425. 2 indexed citations
4.
Bibby, B., Niluja Thiruthaneeswaran, Lingjian Yang, et al.. (2021). Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer. BMC Urology. 21(1). 96–96. 6 indexed citations
5.
Thiruthaneeswaran, Niluja, B. Bibby, Peter Hoskin, et al.. (2021). Lost in application: Measuring hypoxia for radiotherapy optimisation. European Journal of Cancer. 148. 260–276. 24 indexed citations
6.
Tran, Maxine, B. Bibby, Lingjian Yang, et al.. (2020). Independence of HIF1a and androgen signaling pathways in prostate cancer. BMC Cancer. 20(1). 469–469. 28 indexed citations
7.
Thiruthaneeswaran, Niluja, B. Bibby, Rita Pereira, et al.. (2020). OC-1031: The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer. Radiotherapy and Oncology. 152. S1086–S1087. 5 indexed citations
8.
Smith, Timothy, Joely J. Irlam, Brian R. Lane, et al.. (2020). Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue. Scientific Reports. 10(1). 17258–17258. 13 indexed citations
9.
Buckley, Amy, B. Bibby, Margaret R. Dunne, et al.. (2019). Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells. Pharmaceuticals. 12(1). 33–33. 8 indexed citations
10.
11.
Choudhury, Ananya, Lingjian Yang, Darren L. Roberts, et al.. (2018). Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer.. Journal of Clinical Oncology. 36(6_suppl). 5–5. 1 indexed citations
12.
Thiruthaneeswaran, Niluja, et al.. (2018). Repurposing of FDA-approved Therapeutics to Identify Novel Radiosensitisers in Hypoxic Prostate Cancer. Clinical Oncology. 30(3). 195–196.
13.
Yang, Lingjian, Darren L. Roberts, Mandeep Takhar, et al.. (2017). Hypoxia Gene Expression Signature Independently Predicts Prognosis for Prostate Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 99(2). S201–S201. 1 indexed citations
14.
Lynam‐Lennon, Niamh, B. Bibby, Ann Mongan, et al.. (2016). Low MiR-187 Expression Promotes Resistance to Chemoradiation Therapy In Vitro and Correlates with Treatment Failure in Patients with Esophageal Adenocarcinoma. Molecular Medicine. 22(1). 388–397. 27 indexed citations
15.
Bibby, B., et al.. (2016). Investigating the role of microRNA-187 as a modulator of chemoradiation sensitivity in oesophageal adenocarcinoma. European Journal of Cancer. 61. S158–S159. 1 indexed citations
16.
Lynam‐Lennon, Niamh, Susan Heavey, B. Bibby, et al.. (2016). MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype. Oncotarget. 8(7). 11400–11413. 36 indexed citations
17.
Bibby, B., Christopher Cawthorne, John Reynolds, & Stephen E. Maher. (2016). MicroRNA-330-5p downregulation in oesophageal adenocarcinoma is a potential therapeutic target for enhancing chemoradiation sensitivity in patients. European Journal of Cancer. 61. S158–S158. 1 indexed citations
18.
Bibby, B., John V. Reynolds, & Stephen G. Maher. (2015). MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma. PLoS ONE. 10(7). e0134180–e0134180. 33 indexed citations
19.
Reynolds, Steven, et al.. (2015). Measurement of the acute metabolic response to hypoxia in rat tumours in vivo using magnetic resonance spectroscopy and hyperpolarised pyruvate. Radiotherapy and Oncology. 116(3). 392–399. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ghazal Haddad Breakdown of academic impact, for papers by Ольга Викторовна Николаева Breakdown of academic impact, for papers by Qiaomei Guo Breakdown of academic impact, for papers by Vandana Sandhu Breakdown of academic impact, for papers by Lori Kollath Breakdown of academic impact, for papers by Anna Bellmunt Breakdown of academic impact, for papers by Lauren Carcas Breakdown of academic impact, for papers by Rhafaela Lima Causin Breakdown of academic impact, for papers by Ray Manneh Kopp Breakdown of academic impact, for papers by Qian Guo
Rankless by CCL
2026